U.S. patients and clinics to benefit from new revolutionary beam-shaping device
Elekta receives FDA 510(k) clearance for Agility MLC solution Stockholm, Sweden, June 14 – Elekta announced today it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for Agility™*, a revolutionary beam-shaping device integrated into the head of a linear accelerator (linac). Patients and clinics in the US will now be able to benefit from the speed and reliability of this new MLC design. Elekta has collaborated closely with leading hospitals and research institutions to develop a solution that can increase the throughput of patients while delivering